Home News & Events Diabetes drug may reduce risk of long COVID; The latest health stories...

Diabetes drug may reduce risk of long COVID; The latest health stories from around the world

The risk was 41% lower for the metformin group than for a comparison group receiving a placebo. The study presents the first evidence from a randomized clinical trial that a medication taken by patients who have acute symptoms such as cough and fever can reduce the risk of Long Covid, an ill-defined, chronic condition with symptoms that can include extreme fatigue, breathlessness, and brain fog. About 1,100 U.S. trial participants were given placebo or metformin within 7 days of becoming ill. In the following 180 to 300 days, 10.4% in the placebo group reported being diagnosed with Long Covid versus 6.3% in the metformin group.